JAMES MICHAEL LEONARDO
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CHAMBERSBURG, PA NPI 1285699017
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology PA Novocure GmbH All categories
General Payments — all program years on this page
$4,618.84
- Category: General Payments
- Program years: PY2019–2022
- Record count: 219
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $1,034.86 across 47 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $834.86 | 46 |
| Honoraria | $200.00 | 1 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novocure GmbH | $200.00 | 1 |
| Amgen Inc. | $117.15 | 5 |
| Daiichi Sankyo Inc. | $70.32 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $67.12 | 4 |
| Celgene Corporation | $56.71 | 4 |
| Acerta Pharma LLC | $52.32 | 3 |
| Regeneron Healthcare Solutions, Inc. | $47.88 | 2 |
| E.R. Squibb & Sons, L.L.C. | $31.14 | 2 |
| Genentech USA, Inc. | $30.95 | 3 |
| PFIZER INC. | $30.86 | 2 |
| Lilly USA, LLC | $29.01 | 2 |
| Janssen Biotech, Inc. | $26.52 | 1 |
| GENZYME CORPORATION | $24.74 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $24.72 | 1 |
| EISAI INC. | $24.34 | 1 |
| BeiGene USA, Inc. | $23.90 | 1 |
| Adaptive Biotechnologies Corporation | $22.98 | 1 |
| Exelixis Inc. | $22.64 | 1 |
| Merck Sharp & Dohme Corporation | $19.33 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.20 | 1 |
| Myriad Genetic Laboratories, Inc. | $17.47 | 1 |
| Astellas Pharma US Inc | $17.38 | 1 |
| Karyopharm Therapeutics Inc. | $15.88 | 1 |
| EMD Serono, Inc. | $15.05 | 1 |
| SEAGEN INC. | $14.34 | 1 |
| Pharmacyclics LLC, An AbbVie Company | $12.91 | 1 |
By program year
Records — PY2022 (47)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.